-

Cresco Labs Announces Voting Results of Its Annual Meeting of Shareholders

CHICAGO--(BUSINESS WIRE)--Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco Labs” or “the Company”), a vertically integrated, multi-state operator and the cannabis industry’s No. 1 producer of branded products, conducted its annual meeting of shareholders (the “Meeting”) on June 30, 2023 at 11 a.m. (Eastern Time).

At the Meeting, the number of directors on the board of directors of the Company for the ensuing year was fixed at ten (10) by the shareholders and the following nominees for election as directors of the Company were elected by a majority of votes cast by the shareholders virtually present or represented by proxy at the Meeting:

  • Charles Bachtell
  • Robert M. Sampson
  • John R. Walter
  • Gerald F. Corcoran
  • Thomas J. Manning
  • Randy D. Podolsky
  • Marc Lustig
  • Michele Roberts
  • Carol Vallone
  • Tarik Brooks

Further, Marcum LLP was reappointed as the Company’s auditor for the ensuing year.

About Cresco Labs Inc.

Cresco Labs is one of the largest vertically integrated, multi-state cannabis operators in the United States, with a mission to normalize and professionalize the cannabis industry. Employing a consumer-packaged goods (“CPG”) approach, Cresco Labs is the largest wholesaler of branded cannabis products in the U.S. Its brands are designed to meet the needs of all consumer segments and comprised of some of the most recognized and trusted national brands including Cresco®, High Supply®, Mindy’s™, Good News®, Remedi™, Wonder Wellness Co.® and FloraCal Farms®. Cresco Labs’ national dispensary brand, Sunnyside®, is a wellness-focused retailer created to build trust, education and convenience for both existing and new cannabis consumers. Recognizing that the cannabis industry is poised to become one of the leading job creators in the country, Cresco Labs operates the industry’s largest Social Equity and Educational Development initiative, SEED™, which was established to ensure that all members of society have the skills, knowledge and opportunity to work and own businesses in the cannabis industry. Learn more about Cresco Labs at www.crescolabs.com.

Facebook: Cresco Labs

Instagram: Cresco Labs

Twitter: Cresco Labs

Contacts

Media:
Jason Erkes, Cresco Labs
Chief Communications Officer
press@crescolabs.com

Investors:
Megan Kulick, Cresco Labs
Senior Vice President, Investor Relations
investors@crescolabs.com

For general Cresco Labs inquiries:
312-929-0993
info@crescolabs.com

Cresco Labs

CNSX:CL

Release Summary
Cresco Labs Announces Voting Results of Its Annual Meeting of Shareholders
Release Versions

Contacts

Media:
Jason Erkes, Cresco Labs
Chief Communications Officer
press@crescolabs.com

Investors:
Megan Kulick, Cresco Labs
Senior Vice President, Investor Relations
investors@crescolabs.com

For general Cresco Labs inquiries:
312-929-0993
info@crescolabs.com

Social Media Profiles
More News From Cresco Labs

Cresco Labs to Report Second Quarter 2026 Financial Results on August 6, 2026

CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced it will report financial results for the quarter ended June 30th, 2026 on Thursday, August 6, 2026 before the market opens. The Company will host a conference call and webcast to discuss its financial results and provide investors with ke...

Cresco Labs Closes US$50 Million Revolving Credit Facility with Needham Bank

CHICAGO--(BUSINESS WIRE)--Access to commercial bank financing enhances financial flexibility and supports Cresco Labs’ disciplined growth and consolidation strategy....

Cresco Labs Marks Historic Step Forward with Medical Cannabis Facility DEA Registration

CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced that it registered certain state-licensed medical cannabis facilities with the U.S. Drug Enforcement Administration (“DEA”) following the federal rescheduling of medical cannabis to Schedule III under the Controlled Substances...
Back to Newsroom